News Analysis

Dishman Carbogen Amcis gets nod for MDR TB Medicine production in India

Updated on 12 September 2019 12:47 PM

Drug Controller General of India has approved MDR Tuberculosis (TB) Medicine Bedaquiline Fumarate (BULK) for Dishman Carbogen Amcis for production in India. The company has adequate production facility to produce required quantity of this life saving medicine.

Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.